Heidi Health has announced the decision to cut its workforce by 18 percent globally, pointing to “difficult choices” around where to focus teams and investment.
In a message from co-founder and CEO Tom Kelly, the company shared that the announcement had been made to its workforce during an “all hands” meeting, with notifications sent out to the individuals affected offering help and support with next steps.
A review of priorities has brought about a commitment to invest more in customer support and R&D, it states, adding: “Unfortunately, it also means some roles will be impacted. These changes do not reflect the contribution, dedication or value of our departing Heidi’s.”
Severance and benefits packages are being provided to those let go, and Heidi commits to using its networks to help people find their next role.
“Thank you for everything you have put into Heidi,” the CEO says. “Your work has shaped this company, helped clinicians spend more time caring for patients and made a lasting difference to people around the world. I know that words cannot make today easier, but hope you each leave Heidi knowing how much your contribution has meant.”
A month ago, a LinkedIn post reported $340 million in new funding, pointing to the investment as “fuel” for Heidi’s greatest evolution yet. “We turned a scribe into an AI Care Partner,” it notes. “We built task-specific clinical models that run circles around the frontier labs on medical precision, running securely and compliantly in every region. As for what’s next? We’re almost ready to share it with you.”
Wider trend: AVT
Digital Health and Care Wales has chosen to abandon its £10m ambient voice technology procurement, citing a “limited number of suppliers successfully meeting the Conditions of Participation requirements”. The organisation launched the open framework agreement in August, aiming to support the adoption of the technology to improve clinical documentation processes. It shared its intent to use the exercise to maintain a “pre-qualified list” of AVT suppliers, with conditions enabling participation and the need to achieve a minimum evaluation threshold. The decision to abandon the process has been made following the completion of the Conditions of Participation assessment stage, DHCW notes, which reviewed the procurement outcome.
Mid Cheshire Hospitals NHS Foundation Trust has rolled out ambient voice technology across more locations and community services following a successful trial. The initial trial of the Lyrebird AVT solution incorporated services including same day emergency care, dermatology, rheumatology, and urology. The technology will now be used in services including the emergency department, paediatrics, orthopaedics, the stroke unit, and the minor injuries unit, MCHT reports. More than 300 members of staff have been trained on using the technology so far, according to Rosie Redstone, digital senior project manager.
The North West London Acute Provider Group has shared its intent to procure an ambient voice technology solution, launching a market engagement opportunity. The group, covering Imperial College Healthcare NHS Trust, Chelsea and Westminster Hospital NHS Foundation Trust, London North West University Healthcare NHS Trust, and The Hillingdon Hospitals NHS Foundation Trust; estimates that a future contract for the solution will run from 1 April 2027 to 31 March 2030, a total of three years.
